Xin Hailiang

Dr. Xin Hailiang

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
NZNai-Dan Zhang
Nai-Dan Zhang
THTing Han
Ting Han
BHBao-Kang Huang
Bao-Kang Huang
KRKhalid Rahman
Khalid Rahman
YJYi-Ping Jiang
Yi-Ping Jiang
YLYi-Min Li
Yi-Min Li

28 September 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HZHong Zhang
Hong Zhang
CYCheng-Hao Yu
Cheng-Hao Yu
YJYi-Ping Jiang
Yi-Ping Jiang
CPCheng Peng
Cheng Peng
KHKun He
Kun He
XHXin Hailiang
Xin Hailiang
Polydatin is one of main compounds in Polygonum cuspidatum, a plant with both medicinal and nutritional value. The possible hepatoprotective effects of polydatin on acute liver injury mice induced by carbon tetrachloride (CCl4) and the mechanisms involved were investigated. Intraperitoneal injection of CCl4 (50 µl/kg) resulted in a significant increase in the levels of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT) and hepatic malondialdehyde (MDA), also a marked enhancement in the expression of hepatic tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS) and nuclearfactor-kappa B (NF-κB). On the other hand, decreased glutathione (GSH) content and activities of glutathione transferase (GST), superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) were observed following CCl4 exposure. Nevertheless, all of these phenotypes were evidently reversed by preadministration of polydatin for 5 continuous days. The mRNA and protein expression levels of hepatic growth factor-beta1 (TGF-β1) were enhanced further by polydatin. These results suggest that polydatin protects mice against CCl4-induced liver injury through antioxidant stress and antiinflammatory effects. Polydatin may be an effective hepatoprotective agent and a promising candidate for the treatment of oxidative stress- and inflammation-related diseases.

20 September 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
KLKun Li
Kun Li
TXTianshuang Xia
Tianshuang Xia
YJYiping Jiang
Yiping Jiang
NWNani Wang
Nani Wang
LLLiyong Lai
Liyong Lai
XHXin Hailiang
Xin Hailiang

1 November 2013 in Biomedical Reports
Verified
Journal Article
Open access
PDF file
SZShu-Ya Zhang
Shu-Ya Zhang
LHLi-Ya Han
Li-Ya Han
HZHong Zhang
Hong Zhang
XHXin Hailiang
Xin Hailiang
Chaenomeles speciosa (Sweet) Nakai (C. speciosa, Rosaceae family) is an effective medicinal plant, which has long been used in China to treat various diseases, such as rheumatism, cholera, dysentery, enteritis, beriberi and vitamin C deficiency syndrome. A series of chemical constituents, including triterpenoid, phenolic and phenylpropionic acids, flavonoids, saccharides, essential oils and alkaloids, have been isolated from this plant and some have already been evaluated for their biological activities. Pharmacological investigations demonstrated that C. speciosa possesses anti-inflammatory, antinociceptive, antimicrobial, antioxidant, immunoregulatory, antiparkinsonian, hepatoprotective and antitumor properties. The objective of this review was to summarise available up-to-date and comprehensive information on C. speciosa and provide a relevant reference for further investigations.

1 April 2016 in Fitoterapia
Verified
Journal Article
Closed access
ZZZhiguo Zhang
Zhiguo Zhang
QZQiaoyan Zhang
Qiaoyan Zhang
HYHua Yang
Hua Yang
WLWei Liu
Wei Liu
NZNaidan Zhang
Naidan Zhang
XHXin Hailiang
Xin Hailiang

11 January 2019 in Molecules
Verified
Journal Article
Open access
PDF file
TXTianshuang Xia
Tianshuang Xia
XDXin Dong
Xin Dong
YJYiping Jiang
Yiping Jiang
LLLiuyue Lin
Liuyue Lin
ZDZhimin Dong
Zhimin Dong
LQLu-Ping Qin
Lu-Ping Qin
Rehmanniae Radix Preparata (RR), the dry rhizome of Rehmannia glutinosa Libosch., is a traditional herbal medicine for improving the liver and kidney function. Ample clinical and pharmacological experiments show that RR can prevent post-menopausal osteoporosis and senile osteoporosis. In the present study, in vivo and in vitro experiments, as well as a UHPLC-Q/TOF-MS-based metabolomics study, were used to explore the preventing effect of RR on glucocorticoid-induced osteoporosis (GIOP) and its underlying mechanisms. As a result, RR significantly enhanced bone mineral density (BMD), improved the micro-architecture of trabecular bone, and intervened in biochemical markers of bone metabolism in dexamethasone (DEX)-treated rats. For the in vitro experiment, RR increased the cell proliferation and alkaline phosphatase (ALP) activity, enhanced the extracellular matrix mineralization level, and improved the expression of runt-related transcription factor 2 (RUNX2) and osteopontin (OPN) in DEX-injured osteoblasts. For the metabolomics study, a total of 27 differential metabolites were detected in the DEX group vs. the control group, of which 10 were significantly reversed after RR treatment. These metabolites were majorly involved in steroid hormone biosynthesis, sex steroids regulation, and amino acid metabolism. By metabolic pathway and Western blotting analysis, it was further ascertained that RR protected against DEX-induced bone loss, mainly via interfering steroid hormone biosynthesis, as evidenced by the up-regulation of cytochrome P450 17A1 (CYP17A1) and aromatase (CYP19A1), and the down-regulation of 11β-hydroxysteroid dehydrogenase (HSD11B1). Collectively, these results indicated that RR had a notable preventing effect on GIOP, and the action mechanism might be related to steroid hormone biosynthesis.